Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GDF5 antisense RNA 1 (GDF5-AS1) is a long non-coding RNA gene located antisense to the GDF5 gene, which encodes growth differentiation factor 5, a member of the BMP family involved in cartilage and bone formation[5]. GDF5-AS1 itself does not encode a protein and is thought to play a regulatory role by modulating the transcription, stability, or translation of messenger RNA from the GDF5 gene through antisense RNA mechanisms[5]. There are currently no direct reports linking GDF5-AS1 to disease, biomarkers, or drug interactions. The molecule’s relevance is in the regulatory layer of gene expression and its potential future utility as an RNA-targeted therapeutic or diagnostic marker. Most recent evidence and disease association relate to other antisense lncRNAs such as FGD5-AS1, not GDF5-AS1[4][6].
Not applicable for drugs, as no direct drug interactions are documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GDF5 antisense RNA 1 (GDF5-AS1).